Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction

Mitochondria-targeted antioxidants

(2015) Anne O. Oyewole et al.   FASEB JOURNAL

Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction

(2015) Yuliya Mikhed et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing

(2015) Luke X. Zhan et al.   JOURNAL OF VASCULAR SURGERY

Toward a Change in Syntax in Diabetic Foot Care

(2014) David G. Armstrong et al.   JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION

Glycated hemoglobin level is significantly associated with the severity of coronary artery disease in non-diabetic adults

(2014) Anping Cai et al.   Lipids in Health and Disease

Chronic Wounds with Emphasis in Diabetic Foot Ulcers

(2014) Jorge Berlanga-Acosta et al.   Biomed Research International

Generating and Reversing Chronic Wounds in Diabetic Mice by Manipulating Wound Redox Parameters

(2014) Sandeep Dhall et al.   Journal of Diabetes Research

The role of epidermal growth factor in prevention of oxidative injury and apoptosis induced by intestinal ischemia/reperfusion in rats

(2013) Pelin Arda-Pirincci et al.   ACTA HISTOCHEMICA

Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers

(2013) Zhihong Li et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)

(2013) Joseph L. Mills et al.   JOURNAL OF VASCULAR SURGERY

Heberprot-P: a novel product for treating advanced diabetic foot ulcer

(2013) Jorge Berlanga et al.   MEDICC Review

Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

(2013) Isis B Yera-Alos et al.   BMC Pharmacology & Toxicology

Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients

(2012) Mohsen Kerkeni et al.   Diabetes & Vascular Disease Research

Granulation Response and Partial Wound Closure Predict Healing in Clinical Trials on Advanced Diabetes Foot Ulcers Treated With Recombinant Human Epidermal Growth Factor

(2012) C. M. Valenzuela-Silva et al.   DIABETES CARE

Long-Term Prognosis of Diabetic Foot Patients and Their Limbs: Amputation and death over the course of a decade

(2012) S. Morbach et al.   DIABETES CARE

Expression of cell proliferation cycle negative regulators in fibroblasts of an ischemic diabetic foot ulcer. A clinical case report

(2012) Jorge Berlanga-Acosta et al.   International Wound Journal

Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing

(2012) Jorge Berlanga-Acosta et al.   Biomed Research International

Oxidant and antioxidant events during epidermal growth factor therapy to cutaneous wound healing in rats

(2011) Zeynep Kalay et al.   International Wound Journal

Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment

(2011) Jorge Berlanga-Acosta   International Wound Journal

Oxidative Stress and Diabetic Complications

(2010) Ferdinando Giacco et al.   CIRCULATION RESEARCH

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes

(2010) Sho-ichi Yamagishi   EXPERIMENTAL GERONTOLOGY

Oxidative stress, insulin signaling, and diabetes

(2010) Justin L. Rains et al.   FREE RADICAL BIOLOGY AND MEDICINE

Pentosidina: un nuevo biomarcador de las complicaciones en la diabetes mellitus

(2010) Sonia Morales et al.   MEDICINA CLINICA

Hypothesis: the “metabolic memory”, the new challenge of diabetes

(2009) Antonio Ceriello   DIABETES RESEARCH AND CLINICAL PRACTICE

Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure

(2009) José I Fernández-Montequín et al.   International Wound Journal

Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study

(2009) José I Fernández-Montequín et al.   International Wound Journal

Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications

(2009) Jorge Berlanga-Acosta et al.   International Wound Journal

The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes

(2008) Robbert Meerwaldt et al.   Cardiovascular Diabetology

The pro-inflammatory environment in recalcitrant diabetic foot wounds

(2008) Jorge Berlanga Acosta et al.   International Wound Journal

High Levels of Plasma Malondialdehyde, Protein Carbonyl, and Fibrinogen Have Prognostic Potential to Predict Poor Outcomes in Patients With Diabetic Foot Wounds: A Preliminary Communication

(2008) Roma Rattan et al.   International Journal of Lower Extremity Wounds